HRS-1893 - Jiangsu Hengrui Pharma
A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy (clinicaltrials.gov) - May 30, 2023 - P1 | N=98 | Not yet recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd. 
New P1 trial • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Obstructive Hypertrophic Cardiomyopathy
http://clinicaltrials.gov/ct2/show/NCT05879523
 
May 30, 2023
 
Prev